Gynecologic Cancer
News
Olaparib maintenance of most benefit in BRCA mutation carriers
Major finding: The reduction in the risk of progression or death with olaparib versus placebo was greater among patients with a BRCA mutation (...
News
CDC study finds 56% drop in HPV infections
Major finding: Among females aged 14-19 years, the prevalence of HPV infections dropped from 11.5% during the period prior to HPV vaccine...
News
Adding bevacizumab to chemo prolongs life in advanced cervical cancer
Major Finding: Median overall survival was 17.0 months with bevacizumab plus chemotherapy vs. 13.3 months with chemotherapy alone (P = .0035).Data...
News
Bevacizumab plus chemotherapy extends cervical cancer survival
News
Cervical cancer screening with acetic acid saves lives
Major finding: Compared with usual care (no screening), biennial visual inspection of the cervix with acetic acid delivered by health workers...
Conference Coverage
Maintenance pazopanib delays progression of advanced ovarian cancer
Major Finding: The time to progression or death was 17.9 months with pazopanib and 12.3 months with placebo (hazard ratio, 0.77).Data Source: A...
Article
Benign metastasizing leiomyoma: ‘a sheep in wolf’s clothing’
News
Routine bilateral salpingectomy with hysterectomy gains acceptance
Major finding: The bilateral salpingectomy rate increased from 3% in 2009 and 2010 to 73% in the first 6 months of 2012.Data source: A...
News
Genetic profiles more clearly defined in endometrial cancer, AML
News
Timely palliative consult affects end-of-life care in gynecologic cancer patients
Major finding: Patients receiving timely palliative care had lower scores for aggressive care at the end of life (0 vs. 2) and, in their last 14...
News
Intraperitoneal chemo superior in low-volume residual ovarian cancer
Major Finding: With a median follow-up of nearly 11 years, relative to their counterparts given IV chemotherapy, women given IP chemotherapy had...